Alpha 2.0
Login Register
» Articles » PMID: 26769924

Complete Genome Sequence of Helicobacter Pylori Strain 29CaP Isolated from a Mexican Patient with Gastric Cancer

Overview
Journal Genome Announc
Publisher American Society for Microbiology
Date 2016 Jan 16
PMID 26769924
Citations 6
Authors
Eduardo Mucito-Varela
Gonzalo Castillo-Rojas
Miguel A Cevallos
Luis Lozano
Enrique Merino
Gamaliel Lopez-Leal
Yolanda Lopez-Vidal
Affiliations
Soon will be listed here.
Abstract

Helicobacter pylori infection is a risk factor for the development of gastric cancer and other gastroduodenal diseases. We report here the complete genome sequence of H. pylori strain 29CaP, isolated from a Mexican patient with gastric cancer. The genomic data analysis revealed a cag-negative H. pylori strain that contains a prophage sequence.

Citing Articles

Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori.

Wang L, Yao H, Morgan D, Lau K, Leung S, Ho J Nat Commun. 2023; 14(1):2196.

PMID: 37069161 PMC: 10110541. DOI: 10.1038/s41467-023-37975-y.

Biochemical and Kinetic Characterization of the Glucose-6-Phosphate Dehydrogenase from Strain 29CaP.

Ortiz-Ramirez P, Hernandez-Ochoa B, Ortega-Cuellar D, Gonzalez-Valdez A, Martinez-Rosas V, Morales-Luna L Microorganisms. 2022; 10(7).

PMID: 35889079 PMC: 9323780. DOI: 10.3390/microorganisms10071359.

Identification and In Silico Characterization of Novel Glucose-6-Phosphate Dehydrogenase Inhibitors.

Hernandez-Ochoa B, Navarrete-Vazquez G, Aguayo-Ortiz R, Ortiz-Ramirez P, Morales-Luna L, Martinez-Rosas V Molecules. 2021; 26(16).

PMID: 34443540 PMC: 8401736. DOI: 10.3390/molecules26164955.

Integrative and Conjugative Elements of Are Hypothetical Virulence Factors Associated With Gastric Cancer.

Mucito-Varela E, Castillo-Rojas G, Calva J, Lopez-Vidal Y Front Cell Infect Microbiol. 2020; 10:525335.

PMID: 33194783 PMC: 7604443. DOI: 10.3389/fcimb.2020.525335.

Genetic populations and virulence factors of Helicobacter pylori.

Kabamba E, Tuan V, Yamaoka Y Infect Genet Evol. 2018; 60:109-116.

PMID: 29471116 PMC: 5891324. DOI: 10.1016/j.meegid.2018.02.022.

References
1.
Graham D . Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015; 148(4):719-31.e3. PMC: 4375058. DOI: 10.1053/j.gastro.2015.01.040. View
2.
Lin D, Koskella B . Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism-mutualism continuum. Evol Appl. 2015; 8(1):9-22. PMC: 4310578. DOI: 10.1111/eva.12231. View
3.
Sampieri C, Mora M . Gastric cancer research in Mexico: a public health priority. World J Gastroenterol. 2014; 20(16):4491-502. PMC: 4000486. DOI: 10.3748/wjg.v20.i16.4491. View
4.
Polk D, Peek Jr R . Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer. 2010; 10(6):403-14. PMC: 2957472. DOI: 10.1038/nrc2857. View
5.
Loughlin M . Novel therapeutic targets in Helicobacter pylori. Expert Opin Ther Targets. 2003; 7(6):725-35. DOI: 10.1517/14728222.7.6.725. View